The revised workplan for the Accelerating Clinical Trial in the EU (ACT EU) initiative is now available
The revised workplan for the Accelerating Clinical Trial in the EU (ACT EU) initiative is now available on the ACT EU website.
It outlines the programme's deliverables for 2025-2026, incorporating feedback from the multi-stakeholder platform advisory group and other channels.
Key focus areas include:
- The operation of the Clinical Trials Regulation
- Maximising clinical trial impact
- Facilitating clinical trials in public health emergencies
Clinical trial analytics, training, and communication remain integral to ACT EU’s work, interlinked with all other activities.
The workplan also outlines the fundamental role of ACT EU regulatory partners involved in clinical trials, working together to improve the landscape for clinical research in the European Union.
The workplan is reviewed on a regular basis and revised to better address stakeholder priorities, as identified by the MSP Advisory Group. For more information, see the ACT EU website.